» Articles » PMID: 15539713

Normal Pulmonary Capillary Blood Volume in Patients with Chronic Infiltrative Lung Disease and High Pulmonary Artery Pressure

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2004 Nov 13
PMID 15539713
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: Pulmonary capillary blood volume (Qc), a component of diffusing capacity of the lung for carbon monoxide (Dlco), is increased in postcapillary pulmonary hypertension due to valve disease, but is decreased in primitive and thromboembolic pulmonary hypertension. This study was performed to evaluate which way pulmonary Qc is affected in patients with chronic infiltrative lung disease according to the value of systolic pulmonary artery pressure (SPAP).

Patients And Methods: Twenty-four patients who were nonsmokers and had chronic infiltrative lung disease secondary to connective tissue disease (12 patients), asbestosis (1 patient), sarcoidosis (5 patients), or of unknown origin (6 patients), and 8 control subjects underwent pulmonary function tests and Doppler echocardiography.

Measurements And Results: Total lung capacity, alveolar-arterial oxygen pressure difference, Dlco, and conductance of the alveolar-capillary membrane (Dm) did not differ between patients with low SPAP (LPAP) [ie, < 30 mm Hg] or high SPAP (HPAP). Patients with LPAP, but not HPAP, experienced significant decreases in pulmonary Qc, whatever the cause of the disease. There was a strong positive correlation between SPAP and Qc scaled by Dm to account for infiltrative disease severity (r = 0.68; p < 0.001).

Conclusions: We thus conclude that pulmonary Qc is not decreased as expected in patients with chronic infiltrative lung disease and high pulmonary artery pressure. A high Qc/Dm ratio should encourage the physician to look for HPAP compatible with pulmonary hypertension, whatever the etiology of lung infiltrative disease.

Citing Articles

Recent advances in the management of pulmonary hypertension with interstitial lung disease.

Waxman A, Elia D, Adir Y, Humbert M, Harari S Eur Respir Rev. 2022; 31(165).

PMID: 35831007 PMC: 9724812. DOI: 10.1183/16000617.0220-2021.


Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations.

de Picciotto C, El Hajjam M, Karam C, Chinet T, Bonay M Respir Res. 2019; 20(1):137.

PMID: 31272464 PMC: 6611029. DOI: 10.1186/s12931-019-1106-y.


Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.

Barbera J, Blanco I Curr Hypertens Rep. 2015; 17(8):62.

PMID: 26115628 DOI: 10.1007/s11906-015-0574-9.


CO and NO pulmonary diffusing capacity during pregnancy: Safety and diagnostic potential.

Zavorsky G, Blood A, Power G, Longo L, Artal R, Vlastos E Respir Physiol Neurobiol. 2010; 170(3):215-25.

PMID: 20149901 PMC: 3725751. DOI: 10.1016/j.resp.2010.02.001.


Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.

Overbeek M, Groepenhoff H, Voskuyl A, Smit E, Peeters J, Vonk-Noordegraaf A Respir Res. 2008; 9:68.

PMID: 18828919 PMC: 2576177. DOI: 10.1186/1465-9921-9-68.